CINCINNATI–Meridian Bioscience, Inc. (NASDAQ:VIVO) is pleased to announce the launch of a new Clostridium difficile rapid test, ImmunoCard C. difficile GDH. This assay detects the common antigen, Glutamate dehydrogenase, produced by toxigenic and non-toxigenic strains of Clostridium difficile. Toxigenic strains of Clostridium difficile are frequently associated with hospital and community acquired diarrhea and can lead […]
Joint Sales, Research and DevelopmentBeijing, China / Wetzlar, Germany. China Medical Technologies, Inc. (CMED) (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic (“IVD”) company, and Leica Biosystems, a division of Leica Microsystems, a world leader in microscopes and scientific instruments, today announced that they have established a sales, research and development collaboration to co-develop and […]
IRVINE, Calif. — CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has received its Clinical Laboratory Permit from the New York State Department of Health. The permit allows the Company to immediately begin receiving specimens for DNAarray™ Postnatal Developmental Testing. The DNAarray tests are based on aCGH technology, which provides physicians with a comprehensive genomic evaluation […]
GERMANTOWN, Maryland and HILDEN, Germany – QIAGEN today announced it has completed its second U.S. submission of the therascreen® KRAS RGQ PCR Kit for use as a companion diagnostic paired with Erbitux® (cetuximab), a leading drug for treatment of patients with metastatic colorectal cancer (mCRC). Erbitux is marketed in the United States by Bristol-Myers Squibb […]
CAMBRIDGE, Mass.–Firefly BioWorks, Inc., a manufacturer of universally compatible multiplex assays, announced today it was awarded a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute for microRNA profiling. MicroRNAs are an emerging class of biomarkers that are proving to be important indicators for early diagnosis of cancer and other […]
FREDERICK, Md. – Akonni Biosystems, a molecular diagnostics company that develops novel nucleic acid extraction and microarray-based testing systems designed to rapidly and economically analyze biological samples, today announced receipt of a $300K grant from the National Institutes of Health (NIH). The award will enable Akonni to accelerate the research and development of a closed […]
SEATTLE–NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it is initiating the first in a series of studies to evaluate the clinical utility of the NanoString Breast Cancer Intrinsic Subtyping Assay. The initial investigation will utilize samples from the TransATAC study […]
Baltimore, MD and Cambridge, UK – BD Diagnostics, a segment of global medical technology company BD, and Lab21, a global leader in personalized healthcare, announced today a collaboration to develop a state-of-the-art molecular diagnostic assay to detect the life-threatening Aspergillus fungus using the new fully automated BD MAX™ Molecular Testing System. “The potential to detect […]
VENLO, The Netherlands – QIAGEN N.V. (“QIAGEN”) welcomes the announcement made today by Cellestis Limited (“Cellestis”) that Cellestis shareholders have approved QIAGEN’s acquisition of all of the ordinary shares in Cellestis shares by way of a scheme of arrangement (“Scheme”). Details of the voting are set out in Cellestis’ announcement released earlier today. “We are […]
Renishaw Diagnostics Ltd, the developers of the RenDx™ Multiplex Assay System for infectious disease research and diagnosis today announced that it has created another 8 jobs; almost a 30% increase on its current workforce. Renishaw Diagnostics Ltd, the developers of the RenDx™ Multiplex Assay System for infectious disease research and diagnosis today announced that it […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
